Look at yesterdays presentation and see the difference for potential market between covid testing and STI's. That's where the money is. Most invested pre-covid. Covid has allowed for additional revenue and for the product to get out there, almost free marketing in a sense.
GSS was around well before covid came along, yet once it did, they adjusted rapidly and have done well. Testing wont dissapear overnight
Ann: Half Yearly Report and Accounts, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
70.0¢ |
Change
-0.005(0.71%) |
Mkt cap ! $158.6M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 72.0¢ | 68.0¢ | $162.1K | 232.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10880 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 22017 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| GSS (ASX) Chart |